Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02357147
Title Study of the Safety and Efficacy of Amatuximab in Combination With Pemetrexed and Cisplatin in Subjects With Unresectable Malignant Pleural Mesothelioma (MPM). (ARTEMIS)
Acronym ARTEMIS
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Morphotek
Indications
Therapies
Age Groups: adult
Covered Countries USA | ITA | GBR | FRA | DEU | AUS

Facility Status City State Zip Country Details
La Jolla California United States Details
Newark Delaware United States Details
Bethesda Maryland United States Details
Rochester Minnesota United States Details
Philadelphia Pennsylvania United States Details
Dallas Texas United States Details
Spokane Washington United States Details
Camperdown New South Wales Australia Details
Auchenflower Queensland Australia Details
Richmond Victoria 3121 Australia Details
Perth Western Australia Australia Details
Caen France Details
Creteil France Details
La Tronche France Details
Lille France Details
Lyon Cedex France Details
Marseille France Details
Rennes France Details
Toulouse France Details
Berlin Germany Details
Esslingen Germany Details
Frankfurt am Main Germany Details
Gauting Germany Details
Hamburg Germany Details
Hanover Germany Details
Löwenstein Germany Details
Ulm Germany Details
Wöhrendamm Germany Details
Rozzano Milano Italy Details
Pisa Paradisa 2 56124 Italy Details
Alessandria Italy Details
Aviano Italy Details
Bari Italy Details
Bergamo Italy Details
Genoa Italy Details
Genova Italy Details
Monza Italy Details
Orbassano Italy Details
Parma Italy Details
Maidstone Kent United Kingdom Details
Dundee United Kingdom Details
Hereford United Kingdom Details
Leicester United Kingdom Details
London United Kingdom Details
Middlesex United Kingdom Details
Preston United Kingdom Details
Southampton United Kingdom Details
Swindon United Kingdom Details
Taunton United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field